(125 days)
Not Found
No
The description details a standard oscillometric blood pressure monitor using an algorithm to analyze pressure data and detect irregular heartbeats based on fixed percentage differences, not AI/ML.
No
The device is indicated for non-invasive measurement of blood pressure and pulse rate, which is for diagnostic/monitoring purposes, not for treating any condition.
Yes
An automatic blood pressure monitor that provides systolic, diastolic, pulse rate, and cardiac arrhythmia readings is considered a diagnostic device. While it is for non-invasive measurement, the information it provides can be used to diagnose conditions like hypertension or irregular heartbeats.
No
The device description explicitly lists hardware components such as the blood pressure monitor main device, upper arm cuff, batteries, storage bag, and optional power supply. While software is mentioned as controlling the device, it is integrated into a physical hardware system.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- Device Function: The Globalcare GUS610 Automatic Blood Pressure Monitor measures blood pressure and pulse rate non-invasively by applying a cuff to the upper arm. It does not analyze any biological specimens.
- Intended Use: The intended use is for non-invasive measurement of physiological parameters (blood pressure and pulse rate) directly from the body.
Therefore, the device falls under the category of a non-invasive physiological monitoring device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Globalcare GUS610 Automatic Blood Pressure Monitor is indicated for the non-invasive measurement of diastolic and systolic blood pressures and pulse rate of adults by means of an inflatable cuff which is wrapped around the upper arm. The cuff circumference is limited to 22 to 42 cm.
The Globalcare GUS610 automatic Blood Pressure Monitor is indicated for home use for the non-invasive measurement of diastolic and systolic blood pressures and pulse rate of adults by means of an inflatable cuff which is wrapped around the upper arm.
Product codes (comma separated list FDA assigned to the subject device)
DXN
Device Description
The Globalcare GUS610 Blood Pressure Monitor is an automatic upper arm blood pressure monitor intended for non-invasive measurement or monitoring of adults' arterial blood pressure and pulse rate.
The device is powered by batteries or by a mains-connected power supply.
The Globalcare GUS610 Blood Pressure Monitor comprises the following parts:
- Blood pressure monitor main device x1
- Upper arm cuff x1
- 1.5 V LR03 AAA batteries x4
- Storage bag x1
- Instructions for use x1
- 100-240Vac 50/60Hz power supply (optional) with USB cable x1
None of the parts included with the device are supplied in a sterile condition.
The Globalcare GUS610 Blood Pressure Monit is an electronic unit incorporating a screen that displays results and other information relevant to device operation. The device is powered by batteries or by a mains-connected power adapter and is designed for home ('OTC') use.
The clinical outputs from the GUS610 Blood Pressure Monitor are:
- Systolic pressure (mm Hq)
- Diastolic pressure (mm Hq)
- Pulse rate (1/min)
- Cardiac arrhythmia (Irregular heartbeat (IHB)) symbol
- Risk indicator (WHO color scale)
- Hemodynamic Rest Condition (HSD) indication
The device operates on the oscillometric method: pressure sensors on the cuff are used to capture pulse waves during constricted blood flow and the device then computes the results for display by means of an algorithm which analyses the pressures transmitted during arterial oscillations that occur during cuff inflation.
Irreqular heartbeat (IHB) is detected by measuring the interval time between each heartbeat and comparing these values with the average heartbeat interval (heartbeat per minutes shown on the display). If the difference between any heartbeat interval and the average is higher or lower than 25 %, the device shows the irregular heartbeat (IHB) symbol on the display.
The pulse rate is determined by calculating the frequency of the cuff, which are cardiac synchronous.
The GUS610 is controlled by software which calculates the blood pressure (diastolic and pulse rate by the oscillometric method. To do this, it also controls the pneumatic components to inflate the cuff (with a pump), holds the cuff pressure, and then deflates the cuff (by means of a solenoid valve). The software collects the relevant data from the pressure sensor during inflation.
The software also drives the LCD display, from which the user can read the result of the blood pressure and pulse rate measurements and undertakes the Hemodynamic Rest Condition (HSD) detection calculations, and reports whether any irregular heartbeat is occurring.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
upper arm
Indicated Patient Age Range
adults
Intended User / Care Setting
home use / home environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
A clinical investigation was performed to validate the clinical accuracy of the subject device, using the arm sequential method described in subclause 5.2.4.1 of ISO 81060-2:2018+A1:2020 to collect 255 blood pressure datasets from 85 adult subjects.
A clinical investigation was carried out to validate device clinical accuracy. The investigation was performed on Globalcare model GCE610 blood pressure monitor, a device that is technologically identical to the subject device, but which is cleared for marketing in a non-US regulatory jurisdiction. The clinical validation was performed using the same arm sequential method described in subclause 5.2.4.1 of ISO 81060-2:2018+A1:2020 to collect 255 blood pressure datasets from 85 adult subjects.
According to the requirements of ISO 81060-2:2018+A1:2020, a legally available in the US auscultatory reference sphygmomanometer was used for comparison purposes.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical performance study: A clinical investigation was performed to validate the clinical accuracy of the subject device, using the arm sequential method described in subclause 5.2.4.1 of ISO 81060-2:2018+A1:2020 to collect 255 blood pressure datasets from 85 adult subjects. The clinical results indicated that the subject device meets the requirements of ISO 81060-2:2018+A1: 2020, and that there were no adverse events during the investigation.
Effectiveness: The results of the investigation show that the subject device is capable of accurately measuring the blood pressure values in all the subgroups foreseen by standard ISO 81060-2:2018+A1: 2020.
Safety: The study reported no adverse events for the subject device.
Summary: Based on the clinical performance as documented in the clinical study report, the subject device was found to have a safety and effectiveness profile that is substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square and the words "U.S. FOOD & DRUG ADMINISTRATION".
November 22, 2022
Globalcare Medical Technology Co., Ltd. % Roger Gray VP Quality and Regulatory Donawa Lifescience Consluting Srl Piazza Albania 10 Rome, 00153 Italy
Re: K222160
Trade/Device Name: GUS610 Blood pressure monitor Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN Dated: October 20, 2022 Received: October 27, 2022
Dear Roger Gray:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Stephen G. Browning -S
LCDR Stephen Browning Assistant Director Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K222160
Device Name
GUS610 Automatic Blood Pressure Monitor
Indications for Use (Describe)
The Globalcare GUS610 Automatic Blood Pressure Monitor is indicated for the non-invasive measurement of diastolic and systolic blood pressures and pulse rate of adults by means of an inflatable cuff which is wrapped around the upper arm. The cuff circumference is limited to 22 to 42 cm.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
X Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.qov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
| Device Name: | GUS610 Blood Pressure Monitor |
|---|---|
| Type of 510(k) submission: | Traditional |
| Date of submission: | 21 November 2022 |
| Manufacturer: | Globalcare Medical Technology Co., Ltd |
| No.7 Factory, European Industrial Park | |
| No. 39 Mid Industrial Main Road | |
| Xiaolan Town, Zhongshan City | |
| Guangdong, CHINA 528415 | |
| Phone: | +86-760-22589901 |
| FDA Establishment Reg. Number: | 3010880718 |
| 510(k) Owner and Submitter: | Globalcare Medical Technology Co., Ltd |
| No.7 Factory, European Industrial Park | |
| No. 39 Mid Industrial Main Road | |
| Xiaolan Town, Zhongshan City | |
| Guangdong, CHINA 528415 | |
| Owner/Operator Reg. Number: | 10046812 |
| 510(k) Contact: | Mr Roger Gray |
| VP Quality and Regulatory | |
| Donawa Lifescience Consulting | |
| Piazza Albania 10 | |
| 00153 Rome | |
| Italy | |
| Phone: | |
| Fax: | |
| Email: | +39 06 578 2665 |
| +39 06 574 3786 | |
| rgray@donawa.com | |
| FDA Product Code: | DXN |
| FDA Regulation Number: | 21 CFR 870.1130 |
| FDA Classification Name: | Noninvasive blood pressure measurement system |
| Classification Panel: | Cardiovascular |
| Common Name: | Upper arm blood pressure monitor |
| FDA Classification: | Class II |
| Submission Type: | 510(k) |
| Indications for Use: | The Globalcare GUS610 automatic Blood Pressure Monitor is |
| indicated for home use for the non-invasive measurement of | |
| diastolic and systolic blood pressures and pulse rate of adults by | |
| means of an inflatable cuff which is wrapped around the upper | |
| arm. |
4
Device Description:
The Globalcare GUS610 Blood Pressure Monitor is an automatic upper arm blood pressure monitor intended for non-invasive measurement or monitoring of adults' arterial blood pressure and pulse rate.
The device is powered by batteries or by a mains-connected power supply.
The Globalcare GUS610 Blood Pressure Monitor comprises the following parts:
| • Blood pressure monitor main device | x1 |
|---|---|
| • Upper arm cuff | x1 |
| • 1.5 V LR03 AAA batteries | x4 |
| • Storage bag | x1 |
| • Instructions for use | x1 |
| • 100-240Vac 50/60Hz power supply (optional) with USB cable | x1 |
None of the parts included with the device are supplied in a sterile condition.
The Globalcare GUS610 Blood Pressure Monit is an electronic unit incorporating a screen that displays results and other information relevant to device operation. The device is powered by batteries or by a mains-connected power adapter and is designed for home ('OTC') use.
The clinical outputs from the GUS610 Blood Pressure Monitor are:
- . Systolic pressure (mm Hq)
- Diastolic pressure (mm Hq) ●
- . Pulse rate (1/min)
- Cardiac arrhythmia (Irregular heartbeat (IHB)) symbol ●
- Risk indicator (WHO color scale)
- Hemodynamic Rest Condition (HSD) indication
The device operates on the oscillometric method: pressure sensors on the cuff are used to capture pulse waves during constricted blood flow and the device then computes the results for display by means of an algorithm which analyses the pressures transmitted during arterial oscillations that occur during cuff inflation.
Irreqular heartbeat (IHB) is detected by measuring the interval time between each heartbeat and comparing these values with the average heartbeat interval (heartbeat per minutes shown on the display). If the difference between any heartbeat interval and the average is higher or lower than 25 %, the device shows the irregular heartbeat (IHB) symbol on the display.
The pulse rate is determined by calculating the frequency of the cuff, which are cardiac synchronous.
The GUS610 is controlled by software which calculates the blood pressure (diastolic and pulse rate by the oscillometric method. To do this, it also controls the pneumatic components to inflate the cuff (with a pump), holds the cuff pressure, and then deflates the cuff (by means of a solenoid valve). The software collects the relevant data from the pressure sensor during inflation.
The software also drives the LCD display, from which the user can read the result of the blood pressure and pulse rate measurements and undertakes the Hemodynamic Rest Condition (HSD) detection calculations, and reports whether any irregular heartbeat is occurring.
Performance data:
The GUS610 has been tested and found to be in compliance with the following standards:
5
Safety and EMC:
- IEC 60601-1:2005/AMD1:2012 + AMD2:2020 ●
- IEC 60601-1-11:2015/AMD1:2020 .
- IEC 60601-1-2:2014/A1:2020 ●
- IEC 80601-2-30:2018 ●
Clinical performance:
-
ISO 81060-2:2018/AMD1:2020 ●
Cuff biocompatibility: -
ISO 10993-5:2009 ●
-
. ISO 10993-10:2010
Bench tests:
- Internal tests to verify performance ●
- Mains and Battery comparison O
- After 500 hour Life Test has been completed O
- After 12 months storage O
- After drop test O
The results of the above testing assist in the demonstration of substantial equivalence of the subject device with the predicate device.
Clinical performance
A clinical investigation was performed to validate the clinical accuracy of the subject device, using the arm sequential method described in subclause 5.2.4.1 of ISO 81060-2:2018+A1:2020 to collect 255 blood pressure datasets from 85 adult subjects.
A clinical investigation was carried out to validate device clinical accuracy. The investigation was performed on Globalcare model GCE610 blood pressure monitor, a device that is technologically identical to the subject device, but which is cleared for marketing in a non-US regulatory jurisdiction. The clinical validation was performed using the same arm sequential method described in subclause 5.2.4.1 of ISO 81060-2:2018+A1:2020 to collect 255 blood pressure datasets from 85 adult subjects.
According to the requirements of ISO 81060-2:2018+A1:2020, a legally available in the US auscultatory reference sphygmomanometer was used for comparison purposes.
The clinical results indicated that the subject device meets the requirements of ISO 81060-2:2018+A1: 2020, and that there were no adverse events during the investigation. Baseline demographic information regarding participants in the study is provided in Table 1.
| Distributi
| on | Category | Requirement | Actual distribution | Comment | ||
|---|---|---|---|---|---|---|
| Minimum | ||||||
| proportion | Minimum | |||||
| number | Number | Proportio | ||||
| n | ||||||
| Gender | Male | 30% | 26 | 56 | 65.9% | P |
| Female | 30% | 20 | 29 | 34.1% | P | |
| Limb size | ||||||
| range | ||||||
| (cm) | 22-27 | 20% | 17 | 26 | 30.6% | P |
| 27-32 | 20% | 17 | 20 | 23.5% | P | |
| 32-37 | 20% | 17 | 18 | 21.2% | P | |
| 37-42 | 10% | 17 | 21 | 24.7% | P | |
| 22-24.5 | 10% | 9 | 10 | 11.8% | P | |
| 39.5-42 | 10% | 9 | 11 | 12.9% | P | |
| SBP ≤100 | 5% | 4 | 12 | 14.1% | P | |
| Blood | ||||||
| pressure | ||||||
| (mmHg) | SBP ≥140 | 20% | 17 | 19 | 22.4% | P |
| SBP ≥160 | 5% | 4 | 15 | 17.6% | P | |
| DBP ≤60 | 5% | 4 | 10 | 11.8% | P | |
| DBP ≥85 | 20% | 17 | 28 | 32.9% | P | |
| DBP >100 | 5% | 4 | 12 | 14.1% | P |
Table 1: Baseline demographic information
6
Analysis of data from the investigation is based on subclause 5.2.4.1.2 of ISO 81060-2:2018+A1:2020 with the following conclusions:
Effectiveness: The results of the investigation show that the subject device is capable of accurately measuring the blood pressure values in all the subgroups foreseen by standard ISO 81060-2:2018+A1: 2020.
Safety: The study reported no adverse events for the subject device.
Summary: Based on the clinical performance as documented in the clinical study report, the subject device was found to have a safety and effectiveness profile that is substantially equivalent to the predicate device.
Substantial equivalence
The predicate device selected for comparison with the GUS610 Blood Pressure Monitor is:
| Predicate Device: | Blood Pressure Monitor Model GUS622 |
|---|---|
| Sponsor: | Globalcare, China |
| 510(k) Number: | K192609 |
| Clearance Date: | 21 April 2020 |
| FDA Product Code: | DXN |
| Classification Name: | Noninvasive blood pressure measurement system |
| Regulation No: | 21 CFR 870.1130 |
| Class: | II |
Predicate device comparison table:
The following Table 2 provides evidence of substantial equivalence of the subject device with the selected predicate device.
| Table 2: Predicate device comparison table | |||
|---|---|---|---|
| Feature | Subject device | Predicate device | Similarity |
| Device name | GUS610 | GUS622 | N/A |
| Device | |||
| Manufacturer | Globalcare, China | Globalcare, China | N/A |
| 510(k) Reference | This submission | K192609 | N/A |
| FDA Product | |||
| Code | DXN | DXN | Same |
| FDA | |||
| Classification | |||
| Name | Noninvasive blood pressure | ||
| measurement system | Noninvasive blood pressure | ||
| measurement system | Same | ||
| FDA Regulation | |||
| Number | 21 CFR 870.1130 | 21 CFR 870.1130 | Same |
| Device | |||
| description | Automatic upper arm blood | ||
| pressure monitor intended for | |||
| non-invasive measurement or | |||
| monitoring of adults' arterial | |||
| blood pressure and pulse rate | |||
| via an upper arm cuff. | Automatic upper arm blood | ||
| pressure monitor intended for | |||
| non-invasive measurement or | |||
| monitoring of adults' arterial | |||
| blood pressure and pulse rate | |||
| via an upper arm cuff. | Same | ||
| Indications for | |||
| use | The Globalcare GUS610 | ||
| automatic Blood Pressure | |||
| Monitor is indicated for home use | |||
| for the non-invasive | |||
| measurement of diastolic and | |||
| systolic blood pressures and | |||
| pulse rate of adults by means of | |||
| an inflatable cuff which is | |||
| wrapped around the upper arm. | |||
| The cuff circumference is limited | |||
| to 22 to 42 cm. | The Globalcare GUS622 | ||
| automatic Blood Pressure | |||
| Monitor is indicated for home use | |||
| for the non-invasive | |||
| measurement of diastolic and | |||
| systolic blood pressures and | |||
| pulse rate of adults by means of | |||
| an inflatable cuff which is | |||
| wrapped around the upper arm. | |||
| The cuff circumference is limited | |||
| to 22 to 42 cm. | Same | ||
| Table 2: Predicate device comparison table | |||
| Feature | Subject device | Predicate device | Similarity |
| Use environment | Indoor use, home environment | Indoor use, home environment | Same |
| Measuring | |||
| method | Oscillometric method, automatic | ||
| inflation and measurement | |||
| during inflation | Oscillometric method, automatic | ||
| inflation and measurement | |||
| during deflation | Different | ||
| Device | |||
| measurements | |||
| (output | |||
| parameters) | Diastolic and systolic blood | ||
| pressure | |||
| Pulse rate | Diastolic and systolic blood | ||
| pressure | |||
| Pulse rate | Same | ||
| Additional output | |||
| indications | Irregular heart beat | ||
| Hemodynamic instability | Irregular heart beat | ||
| Hemodynamic instability | Same | ||
| Output result | |||
| calculation | Software algorithm | Software algorithm | Same |
| Measurement | |||
| range | Cuff pressure: 0-300 mmHg | ||
| Systolic: 50-280 mmHg | |||
| Diastolic: 30-200 mmHg | |||
| Pulse: 40-200 beats/min | Cuff pressure: 0-300 mmHg | ||
| Systolic: 50-280 mmHg | |||
| Diastolic: 30-200 mmHg | |||
| Pulse: 40-199 beats/min | Same | ||
| Accuracy | Pressure: ±3 mmHg | ||
| Pulse rate: ±5 % | Pressure: ±3 mmHg | ||
| Pulse rate: ±5 % | Same | ||
| External Power | |||
| Supply | Input 100-240 VAC 50/60 Hz 0.5 | ||
| A max; Output 6 VDC | |||
| (+/-5%) / 600mA (optional) | Input 100-240 VAC 50/60 Hz 0.5 | ||
| A max; Output 6 VDC | |||
| (+/-5%) / 600mA (optional) | Same | ||
| Unit voltage | 6V dc | 6V dc | Same |
| Batteries | 4 x AAA alkaline 1.5 VDC | 4 x AAA alkaline 1.5 VDC | Same |
| Battery life | Approx 500 cycles | Approx 500 cycles | Same |
| Standards | |||
| compliance | IEC 60601-1:2005/AMD1:2012 + | ||
| AMD2:2020 | |||
| IEC 60601-1-11:2015/ | |||
| AMD1:2020 | |||
| IEC 60601-1-11:2015/ | |||
| AMD1:2020 | |||
| IEC 60601-1- | |||
| 11:2015/AMD1:2020 | ANSI/AAMI ES60601-1:2005 / | ||
| A2:2010 | |||
| IEC 60601-1-11:2015 | |||
| IEC 60601-1-2:2014 | |||
| IEC 80601-2-30:2009/ | |||
| AMD1:2013 | |||
| ISO 81060-2:2013 | |||
| EN 1060-3:1997+A2:2009 | Subject device complies | ||
| with more recent standards | |||
| Device Protection | IEC 60601-1: Class 2 | IEC 60601-1: Class 2 | Same |
| Applied Part | IEC 60601-1: Type BF | IEC 60601-1: Type BF | Same |
| Memory | 90 x 1 user | 60 x 2 user | Difference has no effect on |
| safety or effectiveness | |||
| Dimensions | L 85 mm x W 170 mm x H 48 | ||
| mm | L 98 mm x W 140 mm x H 53 | ||
| mm | Differences have no effect | ||
| on safety or effectiveness | |||
| Weight | 275 g device without cuff and | ||
| batteries | 207 g device without cuff and | ||
| batteries | Difference has no effect on | ||
| safety or effectiveness |
7
The subject device and the predicate device have many identical or similar properties or features. The differences that exist and are identified in the above table include:
- Blood pressure and pulse rate calculation take place during inflation in the subject device, but ● during deflation in the predicate device. This method produces a faster measurement result display and a lower cuff compression on the patient's arm.
- . The subject device complies with more recent standards than the predicate device.
- The memory function holds different numbers of readings. .
- . Weight and size are different.
None of the identified differences introduce new aspects of safety or effectiveness.
8
Conclusion
The subject and predicate devices have very similar intended uses and fundamental technological characteristics. Any differences in technological characteristics between subject and predicate devices do not raise different questions of safety and effectiveness. The performance data demonstrate that the subject device performs in a similar manner to the predicate device. The clinical data demonstrate that the subject device performs comparably to the predicate device which is legally available in the US for the same intended use. The performance and clinical data together demonstrate that the subject device is substantially equivalent to the predicate device